help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hermus, A. R.
Right arrow Articles by Kloppenborg, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hermus, A. R.
Right arrow Articles by Kloppenborg, P. W.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 2859-2865, Copyright © 1995 by Endocrine Society


ARTICLES

Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome

AR Hermus, AG Smals, LM Swinkels, DA Huysmans, GF Pieters, CF Sweep, FH Corstens and PW Kloppenborg
Department of Medicine, University Hospital Nijmegen, The Netherlands.

We measured bone mineral density (BMD) using dual-energy x-ray absorptiometry in 20 patients with Cushing's syndrome (CS) (14 pre- and 2 postmenopausal women, 4 men) before and in 18 of them also at regular intervals after surgical cure (median duration of follow-up, 36 months). In addition, in the premenopausal women with CS, fasting blood samples and 2-h fasting urine samples for measurement of biochemical parameters of bone and collagen metabolism were collected before and in 9 of them also at regular intervals during the first 2 yr after surgery. Marked osteopenia was present in most patients with active CS (Z-scores: lumbar spine -1.45 +/- 1.44 and femoral neck -1.50 +/- 1.02; mean +/- SD). No consistent change in BMD was observed at 3 and 6 months after surgery. Thereafter BMD increased considerably in almost all patients. For the 15 patients with a follow-up of at least 1 yr, Z- scores at the last evaluation were -0.65 +/- 1.27 for the lumbar spine and -0.98 +/- 1.02 for the femoral neck (both P < 0.002 compared with pretreatment values). In the premenopausal patients, the increase in BMD both in the lumbar spine and in the femoral neck at 24 months was inversely correlated with age (r = -0.733, P < 0.03, and r = -0.667, P < 0.05, respectively). Serum levels of osteocalcin, bone alkaline phosphatase, carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type III procollagen, and the cross-linked telopeptide of type I collagen were not significantly different between the group of 14 premenopausal patients with active CS and a control group of 18 age-matched healthy premenopausal women. However, the urinary hydroxyproline/creatinine ratio was significantly higher in patients with CS (24.6 +/- 9.6 vs. 16.2 +/- 3.5 mumol/mmol, P < 0.01). In all 9 premenopausal patients, serum levels of osteocalcin increased considerably between 0 and 3 months (from 1.04 +/- 0.20 to 3.82 +/- 0.30 nmol/L) (mean +/- SEM, P < 0.0001), indicating a prompt increase of osteoblast activity. Also serum levels of carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type III procollagen, and cross-linked telopeptide of type I collagen, and the urinary hydroxyproline/creatinine ratio increased significantly between 0 and 3 months. Thereafter these levels decreased gradually. We conclude that marked osteopenia in the lumbar spine and femoral neck is present in most patients with active Cushing's syndrome.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
L. K. Nieman, B. M. K. Biller, J. W. Findling, J. Newell-Price, M. O. Savage, P. M. Stewart, and V. M. Montori
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1526 - 1540.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Misra, R. Prabhakaran, K. K. Miller, M. A. Goldstein, D. Mickley, L. Clauss, P. Lockhart, J. Cord, D. B. Herzog, D. K. Katzman, et al.
Prognostic Indicators of Changes in Bone Density Measures in Adolescent Girls with Anorexia Nervosa-II
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1292 - 1297.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
L. Tauchmanova, R. Pivonello, M. C. De Martino, A. Rusciano, M. De Leo, C. Ruosi, C. Mainolfi, G. Lombardi, M. Salvatore, and A. Colao
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism
Eur. J. Endocrinol., September 1, 2007; 157(3): 359 - 366.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. P. Woodrow, C. J. Sharpe, N. J. Fudge, A. O. Hoff, R. F. Gagel, and C. S. Kovacs
Calcitonin Plays a Critical Role in Regulating Skeletal Mineral Metabolism during Lactation
Endocrinology, September 1, 2006; 147(9): 4010 - 4021.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Tauchmanova, R. Pivonello, C. Di Somma, R. Rossi, M. C. De Martino, L. Camera, M. Klain, M. Salvatore, G. Lombardi, and A. Colao
Bone Demineralization and Vertebral Fractures in Endogenous Cortisol Excess: Role of Disease Etiology and Gonadal Status
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1779 - 1784.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
C. Kristo, R. Jemtland, T. Ueland, K. Godang, and J. Bollerslev
Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: A prospective, long-term study
Eur. J. Endocrinol., January 1, 2006; 154(1): 109 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Dovio, L. Perazzolo, G. Osella, M. Ventura, A. Termine, E. Milano, A. Bertolotto, and A. Angeli
Immediate Fall of Bone Formation and Transient Increase of Bone Resorption in the Course of High-Dose, Short-Term Glucocorticoid Therapy in Young Patients with Multiple Sclerosis
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4923 - 4928.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Misra, K. K. Miller, C. Almazan, K. Ramaswamy, W. Lapcharoensap, M. Worley, G. Neubauer, D. B. Herzog, and A. Klibanski
Alterations in Cortisol Secretory Dynamics in Adolescent Girls with Anorexia Nervosa and Effects on Bone Metabolism
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4972 - 4980.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Dennison, P. Hindmarsh, C. Fall, S. Kellingray, D. Barker, D. Phillips, and C. Cooper
Profiles of Endogenous Circulating Cortisol and Bone Mineral Density in Healthy Elderly Men
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3058 - 3063.
[Abstract] [Full Text]


Home page
J Intensive Care MedHome page
I. R. Reid
Glucocorticoid Osteoporosis: Reid IR Glucocorticoid osteoporosis J Intensive Care Med 1999, 14231-242
J Intensive Care Med, September 1, 1999; 14(5): 231 - 242.
[PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Torlontano, I. Chiodini, M. Pileri, G. Guglielmi, M. Cammisa, S. Modoni, V. Carnevale, V. Trischitta, and A. Scillitani
Altered Bone Mass and Turnover in Female Patients with Adrenal Incidentaloma: The Effect of Subclinical Hypercortisolism
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2381 - 2385.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
K. K. Miller and A. Klibanski
Amenorrheic Bone Loss
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1775 - 1783.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Chiodini, V. Carnevale, M. Torlontano, S. Fusilli, G. Guglielmi, M. Pileri, S. Modoni, A. Di Giorgio, A. Liuzzi, S. Minisola, et al.
Alterations of Bone Turnover and Bone Mass at Different Skeletal Sites due to Pure Glucocorticoid Excess: Study in Eumenorrheic Patients with Cushing's Syndrome
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1863 - 1867.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Kleerekoper, R. Schiebinger, and J. P. Gutai
Steroid Therapy for Adrenal Disorders--Getting the Dose Right
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3923 - 3925.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. J. Devoe, W. L. Miller, F. A. Conte, S. L. Kaplan, M. M. Grumbach, S. M. Rosenthal, C. B. Wilson, and S. E. Gitelman
Long-Term Outcome in Children and Adolescents after Transsphenoidal Surgery for Cushing's Disease
J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3196 - 3202.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Osella, M. Terzolo, G. Reimondo, A. Piovesan, A. Pia, A. Termine, P. Paccotti, and A. Angeli
Serum Markers of Bone and Collagen Turnover in Patients with Cushing's Syndrome and in Subjects with Adrenal Incidentalomas
J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3303 - 3307.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Siddiqi, J. M. Burrin, K. Noonan, I. James, D. F. Wood, C. P. Price, and J. P. Monson
A Longitudinal Study of Markers of Bone Turnover in Graves' Disease and Their Value in Predicting Bone Mineral Density
J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 753 - 759.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. Michelson, C. Stratakis, L. Hill, J. Reynolds, E. Galliven, G. Chrousos, and P. Gold
Bone Mineral Density in Women with Depression
N. Engl. J. Med., October 17, 1996; 335(16): 1176 - 1181.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society